Lung Screening Advocates Say Verdict’s In, Attack NCI Randomized Trial As “Outdated.”
...
Lung Screening
Lung cancer researcher Claudia Henschke accepted $3.6 million from the parent company of cigarette maker Liggett Group Ltd., The Cancer Letter has found.
NEJM Sanctioned For Giving CME Credit For Controversial Lung Screening Paper; ACCME Demanded Corrective Action
...
USPSTF’s Michael LeFevre: Lung Screening Can Save More Lives With Fewer Screens Than Mammography
...
With a “B” from USPSTF, Low-Dose CT Screening For Lung Cancer Earns Coverage Under ACA
...
What? Only a “B”? NLST Co-Principal Investigator Begs to Differ with USPSTF Lung Cancer Screening Grade
...
The U.S. Preventive Services Task Force released its final recommendation statement on screening for lung cancer with low-dose computed tomography.
The Centers for Medicare and Medicaid Services is facing the formidable challenge of deciding what kinds of patients should be screened for lung cancer.
Ella KazerooniThe Cancer Letter asked Ella Kazerooni, a professor of radiology at the University of Michigan, chair of the American College of Radiology Committee on Lung Screening, and vice chair of the lung screening panel of the National Comprehensive Cancer Network, to lay out the rationale for a proposal for broad coverage for lung screening.
Almost one decade ago, Laurie Fenton-Ambrose, president and CEO of the Lung Cancer Alliance, described the National Lung Screening Trial as “failed” and “outdated.”
An advisory panel for the Centers for Medicare and Medicaid Services expressed low confidence in low-dose computed tomography as a method for screening for lung cancer in the Medicare population.
When it appeared that CT screening for lung cancer was a shoo-in for Medicare coverage, the Lung Cancer Alliance, an advocacy group, started to certify “screening centers of excellence.”
National coverage for low-dose computed tomography may result in more harm than benefit to the Medicare population at this time, said Steven Woolf, a member of the Medicare Evidence Development & Coverage Advisory Committee.
The Centers for Medicare and Medicaid Services have another six months to decide whether to cover low-dose computed tomography screening. Yet, proponents of screening seem unwilling to take the chance that Medicare coverage would be restrictive.
A coalition of patient advocacy and medical organizations urged the Centers for Medicare & Medicaid Services to cover low-dose computed tomography for Medicare patients at high risk for lung cancer.
CT screening of the lungs of current and former heavy smokers is about to become a Medicare benefit.
